Grass pollen allergen-specific B cell epitope

Grass pollen allergen-specific B cell epitopes are discrete regions on major grass pollen allergens—such as Phl p 1 and Phl p 5A from timothy grass—that are recognized by antibodies produced by the immune system of allergic individuals. These epitopes can be linear or conformational, with several well-characterized continuous regions identified on group 1 and group 5 allergens. For example, five continuous IgE-binding areas have been mapped on Phl p 1, which together bind a significant portion of patient-derived anti-allergen IgE[2][4][5]. Similarly, a highly conserved N-terminal domain in group 5 allergens contains multiple cross-reactive IgE-binding sites critical for effector cell activation in allergy[3]. These B cell epitopes play a central role in mediating Type I hypersensitivity reactions by binding to specific antibodies (IgE), leading to mast cell degranulation and histamine release upon exposure to grass pollens. During allergen immunotherapy, patients may develop blocking IgG4 antibodies against these same regions; this is associated with clinical improvement due to competitive inhibition of pathogenic IgE binding[2]. Immunotherapy strategies may use recombinant fragments or peptides containing these epitopes to induce protective IgG responses or tolerance[2][3]. Epitope-specific IgE and IgG4 antibodies can serve as biomarkers for allergy diagnosis and monitoring immunotherapy efficacy[2]. Potential safety concerns relate to the risk of inducing allergic reactions during immunotherapy using whole allergens or large fragments containing multiple epitopes[2][3]. The term "Grass pollen allergen-specific B cell epitopes" does not refer to a single molecular entity but rather describes various antigenic determinants present within different proteins from diverse grass species. Therefore, it is not considered a therapeutic target like an enzyme or receptor but rather represents structural features relevant for vaccine design and allergy diagnostics. "We propose to use recombinant Phl p 1 fragments for active immunotherapy in order to induce protective IgG responses against IgE epitopes in grass pollen allergic patients"[2]. "The rPhl p 5A fragment represents an alanine-rich protein domain that occurs as a highly conserved segment in group 5 allergens from various grass... indicating that the defined epitope-containing domain represents a highly cross-reactive structure"[3]. Because this entry refers broadly to epitopic regions rather than one defined molecule/receptor/protein family—and because it aggregates information about many possible sequences across different proteins—it should be flagged as incorrect if used where only canonical targets are expected.

Other names

Grass pollen B cell epitopePhl p 1 B cell epitopePhl p 5A B cell epitopeGroup 1 grass pollen allergen B cell epitopeGroup 5 grass pollen allergen B cell epitope